CVS Health Corp (NYSE:CVS) shares are trading marginally lower by 1.52% to $56.97 during Friday’s session. The stock has been muted since the company earlier this week reported worse-than-expected second-quarter sales results and cut its FY24 adjusted EPS guidance below estimates. What Happened?CVS posted sales of $91.23 billion, slightly below the $91.51 billion consensus, with total revenues up 2.6%, driven by growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments, though offset by a decline in the Health Services segment. Adjusted EPS was $1.83, down from $2.21 last ye…